Diligent Investors’s Mesoblast MESO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-5,500
Closed -$12.1K 337
2023
Q4
$12.1K Sell
5,500
-750
-12% -$1.79K ﹤0.01% 319
2023
Q3
$15.4K Sell
6,250
-349
-5% -$1.67K ﹤0.01% 300
2023
Q2
$51.6K Hold
6,599
0.02% 288
2023
Q1
$43.4K Hold
6,599
0.01% 284
2022
Q4
$38.4K Hold
6,599
0.01% 282
2022
Q3
$34K Hold
6,599
0.01% 256
2022
Q2
$29K Hold
6,599
0.01% 258
2022
Q1
$56K Hold
6,599
0.02% 271
2021
Q4
$63K Hold
6,599
0.02% 270
2021
Q3
$99K Hold
6,599
0.03% 239
2021
Q2
$99K Buy
6,599
+250
+4% +$3.92K 0.03% 240
2021
Q1
$105K Buy
6,349
+500
+9% +$9.45K 0.04% 233
2020
Q4
$99K Hold
5,849
0.04% 216
2020
Q3
$217K Hold
5,849
0.1% 170
2020
Q2
$133K Hold
5,849
0.07% 191
2020
Q1
$51K Buy
5,849
+25
+0.4% +$383 0.03% 178
2019
Q4
$86K Hold
5,824
0.04% 216
2019
Q3
$81K Hold
5,824
0.04% 211
2019
Q2
$62K Sell
5,824
-324
-5% -$3.42K 0.03% 218
2019
Q1
$65K Hold
6,148
0.04% 198
2018
Q4
$51K Hold
6,148
0.03% 186
2018
Q3
$100K Hold
6,148
0.05% 197
2018
Q2
$68K Hold
6,148
0.04% 198
2018
Q1
$71K Hold
6,148
0.04% 195
2017
Q4
$72K Hold
6,148
0.05% 195
2017
Q3
$67K Hold
6,148
0.05% 178
2017
Q2
$98K Buy
+6,148
New +$115K 0.07% 178

Other funds holding MESO

Diligent Investors's MESO Position: Q1 2024 in Review

Diligent Investors sold out of Mesoblast (MESO) in Q1 2024, closing a stake of 5,500 shares — an estimated $12.1K sold.

Diligent Investors first reported a position in MESO in Q2 2017 and held it in 27 quarters. The position peaked at $217K in Q3 2020. 26 funds tracked by Wall St. Rank hold MESO as of Q1 2024.

  • Diligent Investors reported no remaining Mesoblast position as of Q1 2024 after selling out during the quarter.
  • Diligent Investors sold 5,500 Mesoblast shares in Q1 2024, an estimated $12.1K.
  • Diligent Investors first reported a position in Mesoblast in Q2 2017 and held it in 27 quarters.
  • Diligent Investors's Mesoblast position peaked at $217K in Q3 2020.
  • 26 funds tracked by Wall St. Rank held Mesoblast as of Q1 2024.

Based on Diligent Investors's 13F filing for Q1 2024, filed 6 May 2024.